Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × HER2-positive Breast Cancer × Trastuzumab × Clear all

Phase

Phase 2 11 Phase 3 7 Phase 2/3 3 Phase 1/2 3 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Stomach Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 HER2-positive Breast Cancer 1 HER-2 Positive Gastric Cancer 1 Brain Neoplasms 1

Interventions

pyrotinib 1 Trastuzumab 1 Taxoids 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06217185 2024-02-28

The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).

Hebei Medical University Fourth Hospital

Phase 4 Recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡